SK
Therapeutic Areas
Kiniksa Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ARCALYST (rilonacept) | Recurrent Pericarditis | Commercial |
| KPL-387 | Recurrent Pericarditis | Phase 2/3 |
| Mavrilimumab | Rare Cardiovascular Diseases | Phase 1 |
| KPL-404 | Rheumatoid Arthritis | Phase 2 |
| Vixarelimab | Prurigo Nodularis (Pruritus) | Phase 2b |